BioSpace News Archive

University of Kansas Health System Cardiologist Ashley Simmons knew there could and should be a better way to measure female heart function.

In an era when consumers are demanding more from producers for better, faster, and stronger products, the biotechnology industry is not exempt.

Cofactor Genomics, the company bridging the precision medicine gap, announced today new data published in Frontiers in Oncology1 by Women & Infants Hospital of Rhode Island.

Illinois Bone & Joint Institute, the largest independent, physician-owned orthopedic practice in Illinois, welcomes two new physicians to the OrthoHealth Program.

Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today that its parent company TissueTech had received clearance from the U.S. Food and Drug Administration (FDA) to proceed with a dosing study using its Investigational New Drug (IND) TTAX03 to treat facet joint pain resulting from Osteoarthritis (OA).

VALBIOTIS (Paris:ALVAL) (FR0013254851 – ALVAL, eligible for PEA / SME), a Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, announces that the preclinical results obtained with TOTUM-854 for arterial hypertension have been selected by the European Society of Hypertension (ESH) and the International Society of Hypertension (ISH).

Ventec Life Systems today announced that its Board of Directors has appointed Jim Alwan as President and Chief Executive Officer, effective March 15, 2021.

Alkahest, Inc., a clinical stage biotechnology company focused on discovering and developing transformative therapies to treat age-related diseases and a subsidiary of Grifols, today announced it will be delivering a presentation of data from a completed study of its therapeutic plasma fraction candidate, GRF6021, in subjects with Parkinson’s disease (PD) and cognitive impairment at the virtual 15th International Conference on Alzheimer’s and Parkinson’s Diseases.

More than 1,000 scientific posters were presented at this year’s European Congress of Radiology (ECR). Only eight were selected to win the top award of Magna cum Laude — including a retrospective study examining the relationship between technical repeats from the UK NHS Breast Screening Program and Volpara’s automated PGMI scoring.

Breckenridge Pharmaceutical, Inc. announces today that the U.S. Food and Drug Administration has granted final approval of its Abbreviated New Drug Application for Everolimus Tablets (generic for Afinitor®).